Treatment With Decitabine (DAC) After Azacitidine (AZA) Failure In High Risk Myelodysplastic Syndrome (MDS) and Advanced Chronic Myelomonocytic Leukemia (CMML)

被引：1
|
作者：
Braun, Thorsten
Cherait, Amina
Berthon, Celine
Willekens, Christophe
Park, Sophie
Rigal, Marthe
Brechignac, Sabine
Harel, Stephanie
Thepot, Sylvain
Quesnel, Bruno
Gardin, Claude
Ades, Lionel
Fenaux, Pierre
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2796.2796
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2796
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failure
    Harel, Stephanie
    Cherait, Amina
    Berthon, Celine
    Willekens, Christophe
    Park, Sophie
    Rigal, Marthe
    Brechignac, Sabine
    Thepot, Sylvain
    Quesnel, Bruno
    Gardin, Claude
    Ades, Lionel
    Fenaux, Pierre
    Braun, Thorsten
    LEUKEMIA RESEARCH, 2015, 39 (05) : 501 - 504
  • [2] Efficacy of salvage with decitabine (DAC) for high-risk (HR)-MDS and advanced CMML after azacitidine (AZA) treatment failure
    Braun, T.
    Cherait, A.
    Rigal, M.
    Brechignac, S.
    Thepot, S.
    Gardin, C.
    Ades, L.
    Fenaux, P.
    LEUKEMIA RESEARCH, 2013, 37 : S150 - S150
  • [3] Transcriptomic Signitures of Azacitidine (AZA) and Decitabine (DAC) Resistance in MDS and CMML
    Darbaniyan, Faezeh
    Class, Caleb
    Montalban-Bravo, Guillermo
    Kanagal-Shamanna, Rashmi
    Estecio, Marcos
    Lu, Yue
    Soltysiak, Kelly A.
    Chien, Kelly S.
    Yang, Hui
    Sasaki, Koji
    Ganan-Gomez, Irene
    Colla, Simona
    Do, Kim-Anh
    Garcia-Manero, Guillermo
    Wei, Yue
    BLOOD, 2021, 138
  • [4] Outcome of Patients (pts) with Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML) Post Decitabine Failure.
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Shan, Jianqin
    O'Brien, Susan
    Cortes, Jorge
    Ravandi, Farhad
    Issa, Jean-Pierre J.
    Kantarjian, Hagop M.
    BLOOD, 2008, 112 (11) : 585 - 586
  • [5] A phase 2 study of azacitidine (5-AZA) with or without birinapant in subjects with higher risk myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML).
    Donnellan, William Bruce
    Diez-Campelo, Maria
    Heuser, Michael
    Ritchie, Ellen K.
    Skolnik, Jeffrey
    Font, Patricia
    Komrokji, Rami S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Efficacy of Azacitidine (AZA) in Autoimmune and Inflammatory Disorders (AID) Associated with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
    Fraison, Jean-Baptiste
    Mekinian, Arsene
    Grignano, Eric
    Kahn, Jean-Emmanuel
    Arlet, Jean-Benoit
    Decaux, Olivier
    Guillaume, Denis
    Buchdahl, Anne-Laure
    Omouri, Mohamed
    Maigne, Gwenola
    Aouba, Achille
    Leon, Nathalie
    Berthier, Sabine
    Liozon, Eric
    Park, Sophie
    Gardin, Claude
    Lortholary, Olivier
    Rossignol, Julien
    Fenaux, Pierre
    Fain, Olivier
    Braun, Thorsten
    BLOOD, 2015, 126 (23)
  • [7] Azacitidine (AZA) and Decitabine (DAC) Show Differential Effects On DNA Methyltransferase (DNMT) Levels in Patients with High Risk (HR) Myelodysplastic Syndrome (MDS)
    Cohen, Aileen
    Huang, Ying-Wen
    Hawtin, Rachael E.
    Ware, Jodi R.
    Cesano, Alessandra
    Kornblau, Steven M.
    BLOOD, 2012, 120 (21)
  • [8] Epigenetic Mechanisms Underlying the Pathogenesis of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)
    Cheng, J. X.
    Anastasi, J.
    Shen, J. Q.
    Watanabe, K.
    Grimley, E.
    Kleinbrink, E.
    Knibbs, R.
    Roulston, D.
    Vardiman, J. W.
    MODERN PATHOLOGY, 2012, 25 : 329A - 330A
  • [9] Epigenetic Mechanisms Underlying the Pathogenesis of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)
    Cheng, J. X.
    Anastasi, J.
    Shen, J. Q.
    Watanabe, K.
    Grimley, E.
    Kleinbrink, E.
    Knibbs, R.
    Roulston, D.
    Vardiman, J. W.
    LABORATORY INVESTIGATION, 2012, 92 : 329A - 330A
  • [10] Efficacy of decitabine in advanced chronic myelomonocytic leukemia (CMML) patients
    Santini, V.
    Allione, B.
    Lunghi, M.
    Levis, A.
    Poloni, A.
    Angelucci, E.
    Onida, F.
    Terenzi, A.
    Finelli, C.
    Ferrero, D.
    LEUKEMIA RESEARCH, 2013, 37 : S17 - S17
12345